Skip to search formSkip to main contentSkip to account menu

Triple Screen

A screening method in which maternal blood levels of alpha-fetoprotein, unconjugated estriol and human chorionic gonadotrophin are calculated. The… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group
Aim:  The aim of the present study was to establish Thai‐specific reference ranges of triple markers for fetal Down syndrome as a… 
2006
2006
Ultrasound screening of fetuses at increased risk for Down syndrome: how many missed diagnoses?
To determine the number of Down syndrome (DS) fetuses identified, amniocenteses performed, and procedure‐related losses incurred… 
Review
2006
Review
2006
Choroid plexus cysts.
BACKGROUND Research shows that there is an association between choroid plexus cysts and aneuploidy. Family physicians treating… 
Highly Cited
2004
Highly Cited
2004
An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
2000
2000
Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
OBJECTIVE Both modest screening performance and declining patient and physician acceptance have stimulated interest in… 
1999
1999
Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
1997
1997
SCREENING FOR DOWN SYNDROME PREGNANCY USING β‐CORE FRAGMENT: PROSPECTIVE STUDY
Two recent publications by Cuckle et al., and one each by Canick et al. and Kellner et al., describe the use of urine β‐core… 
Review
1995
Review
1995
Ethical concerns and future directions in maternal screening for Down syndrome.
Highly Cited
1993
Highly Cited
1993
Presented by invitation at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 11-18, 1992.
Review
1993
Review
1993
The Cost of Choice: A Price Too High in the Triple Screen for Down Syndrome
At US national medical society meetings in 1992, researchers from a major university presented their data on a triple screen of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)